Crossmark

CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing

Crossref DOI link: https://doi.org/10.1073/pnas.1603018113

Published Online: 2016-03-21

Published Print: 2016-04-05

Update policy: https://doi.org/10.1073/pnas.cm10313

Authors

Clark, Andrew J.

Wiley, Devin T.

Zuckerman, Jonathan E.

Webster, Paul

Chao, Joseph

Lin, James

Yen, Yun

Davis, Mark E.
Funding

Funding for this research was provided by:

HHS | NIH | National Cancer Institute (CA 151819)

HHS | NIH | National Cancer Institute (L30 CA179788-01)

HHS | National Institutes of Health (2K12CA001727-21)
License Information

Version of Record valid from 2016-03-21
More Information

Publication History

Published: 2016-03-21